Apparently, not everything is correlated. How about this for a vertical rise..

(Note that the graph self-updates, so in a few days or weeks, it might have a quite different aspect..)

And there are people who argue it isn’t done yet, not by a long shot..

That article seems to have quite an impact (a cool +61% on the day..). Not that surprising when making a case for a $20 share price..

We’re no biotech experts (and not having read those court transcripts) so we can’t add (or subtract) from this, but although not wanting to spoil this party, we do have to add that with an RSI over 90, it might be considered a tad overbought by some..